Open AccessAbstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma
Author(s) -
Amber K. Weiner,
Alexander B. Radaoui,
Nathan M. Kendsersky,
Jo Lynne Harenza-Rokita,
Simone Sidoli,
Karina L. Conkrite,
Zalman Vaksman,
Komal S. Rathi,
Pichai Raman,
Daniel Martı́nez,
Tricia R. Bhatti,
Matthew Tsang,
Bruce Pawel,
Benjamin A. García,
John M. Maris,
Sharon J. Diskin
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-3650
Subject(s) - neuroblastoma , biology , candidate gene , cell , computational biology , cancer research , chemistry , microbiology and biotechnology , cell culture , gene , biochemistry , genetics